1. Home
  2. GTE vs TRDA Comparison

GTE vs TRDA Comparison

Compare GTE & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

HOLD

Current Price

$8.22

Market Cap

293.7M

Sector

Energy

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.37

Market Cap

254.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTE
TRDA
Founded
2003
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.7M
254.7M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
GTE
TRDA
Price
$8.22
$6.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
338.3K
637.9K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$374,460,000.00
$25,421,000.00
Revenue This Year
$1.39
$39.97
Revenue Next Year
$2.84
$50.80
P/E Ratio
N/A
N/A
Revenue Growth
41.99
N/A
52 Week Low
$3.09
$4.93
52 Week High
$9.74
$16.45

Technical Indicators

Market Signals
Indicator
GTE
TRDA
Relative Strength Index (RSI) 41.31 32.16
Support Level $7.30 $5.58
Resistance Level $9.69 $6.90
Average True Range (ATR) 0.48 0.75
MACD -0.14 -0.19
Stochastic Oscillator 6.54 7.12

Price Performance

Historical Comparison
GTE
TRDA

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. The majority of its revenue comes from operations in Colombia.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: